Success Stories: EB-1A Approved for Resident Physician in New York in the Field of Cardiology
Client’s Testimonial:
Thank you so much for this wonderful news. Thanks for all help. I am totally satisfied with your service and detailed work on the petition and step by step guidance.
General Field: Cardiology
Position at the Time of Case Filing: Resident Physician
Country of Origin: India
State of Residence at the Time of Filing: New York
Approval Notice Date: June 10, 2014
Processing Time: 6 days (Premium Processing Requested)
Case Summary:
In this case, the client that we had the opportunity to work with was a Resident Physician from India in the field of Cardiology. His work has focused specifically on thoroughly evaluating the efficacy of a class of drugs known as new oral anticoagulants (NOACs), and specifically how well they prevent blood clots and ischemic attacks in patients suffering from various cardiologic conditions. His work had resulted in 20 peer-reviewed scientific articles and 18 presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 85 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client] has had a major and tangible impact on millions of patients. He has done so by conducting ambitious and definitive evaluations of NOAC efficacy, during the course of which he has identified the specific situations in which NOACs are more effective and cause less dangerous side effects than other anticoagulants like warfarin. This work has had a profound impact on the way these pharmaceuticals are administered by doctors.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Cardiology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 6 days.